A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors

Clinical trial NCT01207323 · COMPLETED

Trial details

NCT number: NCT01207323
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epithelial Tumors, Malignant

Start date: 2010-11-09
Primary completion: 2013-12-03
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.